{"entity":{"type":"insider","cik":"0001589713","url":"/insider/0001589713","json_url":"/insider/0001589713.json","name":"Magnani John L.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":3,"first":"2018-10-18","last":"2022-11-14","span_basis":"filed_date"},"name_variants":[{"name":"Magnani John L.","source":"filing","n_filings":3,"first_seen":"2018-10-18","last_seen":"2022-11-14"}],"transactions":[{"id":6278534,"accession":"0001209191-22-056573","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-056573","line_url":"/filing/0001209191-22-056573#line-1","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"GLYCOMIMETICS INC","issuer_ticker":"GLYC","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001589713","owner_name":"Magnani John L.","owner_display_name":"Magnani John L.","owner_url":"/insider/0001589713","role":"Officer (SVP of Research, CSO)","role_mark":"O","role_mark_label":"Officer (SVP of Research, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Research, CSO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45045.0,"shares_display":"45,045","price_per_share":1.17,"price_display":"1.17","price_state":"stated","total_value":52702.65,"total_display":"52,702.65","total_whole":"52,703","shares_owned_after":366078.0,"shares_owned_after_display":"366,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-11","filed_date":"2022-11-14","scope":"insider"},{"id":6121132,"accession":"0001209191-22-017977","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-017977","line_url":"/filing/0001209191-22-017977#line-1","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"GLYCOMIMETICS INC","issuer_ticker":"GLYC","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001589713","owner_name":"Magnani John L.","owner_display_name":"Magnani John L.","owner_url":"/insider/0001589713","role":"Officer (SVP of Research, CSO)","role_mark":"O","role_mark_label":"Officer (SVP of Research, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Research, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3227.0,"shares_display":"3,227","price_per_share":1.09,"price_display":"1.09","price_state":"stated","total_value":3517.43,"total_display":"3,517.43","total_whole":"3,517","shares_owned_after":321033.0,"shares_owned_after_display":"321,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-09","filed_date":"2022-03-10","scope":"insider"},{"id":6456361,"accession":"0001209191-18-055586","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-055586","line_url":"/filing/0001209191-18-055586#line-3","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"GLYCOMIMETICS INC","issuer_ticker":"GLYC","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001589713","owner_name":"Magnani John L.","owner_display_name":"Magnani John L.","owner_url":"/insider/0001589713","role":"Director, Officer (SVP of Research, CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Research, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3527.0,"shares_display":"3,527","price_per_share":14.02,"price_display":"14.02","price_state":"stated","total_value":49448.54,"total_display":"49,448.54","total_whole":"49,449","shares_owned_after":75793.0,"shares_owned_after_display":"75,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-18","filed_date":"2018-10-18","scope":"insider"},{"id":6456358,"accession":"0001209191-18-055586","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-055586","line_url":"/filing/0001209191-18-055586#line-2","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"GLYCOMIMETICS INC","issuer_ticker":"GLYC","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001589713","owner_name":"Magnani John L.","owner_display_name":"Magnani John L.","owner_url":"/insider/0001589713","role":"Director, Officer (SVP of Research, CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Research, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7273.0,"shares_display":"7,273","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":101822.0,"total_display":"101,822.00","total_whole":"101,822","shares_owned_after":79320.0,"shares_owned_after_display":"79,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-17","filed_date":"2018-10-18","scope":"insider"},{"id":6456355,"accession":"0001209191-18-055586","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-055586","line_url":"/filing/0001209191-18-055586#line-1","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"GLYCOMIMETICS INC","issuer_ticker":"GLYC","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001589713","owner_name":"Magnani John L.","owner_display_name":"Magnani John L.","owner_url":"/insider/0001589713","role":"Director, Officer (SVP of Research, CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Research, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14200.0,"shares_display":"14,200","price_per_share":14.01,"price_display":"14.01","price_state":"stated","total_value":198942.0,"total_display":"198,942.00","total_whole":"198,942","shares_owned_after":86593.0,"shares_owned_after_display":"86,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-16","filed_date":"2018-10-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001253689","name":"GLYCOMIMETICS INC","url":"/issuer/0001253689","role":"Director, Officer (SVP of Research, CSO)","n_filings":3,"first_seen":"2018-10-18","last_seen":"2022-11-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001589713","retrieved_at":"2026-08-26T03:05:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}